載入...

Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.

In a longitudinal study of the evolution of serum beta 2-microglobulin (beta 2-m) levels in 37 patients with myelomatosis, those patients with a level of < 4 mg/l at first presentation had a median survival of 46 months, whereas those with an initial level of > mg/l had a median survival of 15...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Norfolk, D., Child, J. A., Cooper, E. H., Kerruish, S., Ward, A. M.
格式: Artigo
語言:Inglês
出版: Nature Publishing Group 1980
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2010446/
https://ncbi.nlm.nih.gov/pubmed/6159910
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!